Life Sciences BC is pleased to announce the 11th annual Invest in BC presented by Lumira Ventures . This highly anticipated event serves as a premier gathering for life sciences innovators in British Columbia, connecting them with investors and potential partners locally, nationally, and around the world.
We anticipate over 100 investors registered, who are eager to make meaningful connections with BC-based companies. We welcome the life sciences ecosystem to the event, which is a valuable opportunity for gaining business leads, building relationships, attracting capital, and expanding your network.
Last year’s event welcomed over 90 investors from across North America, as well as several trade commissioners and other key stakeholders.
Last Year’s Investors Included:
adMare BioInnovations; AioT Health Venture Capital Fund; Amgen;
Amplitude Ventures; BDC Venture Fund; Bloom Burton; Chrysalix Venture Capital;
Conquest Capital; CQDM; CTI Life Sciences Fund; Daiichi Sankyo; eFund;
FuGene; Genesys Capital; InBC Investment Corp.; J.P. Morgan;
Johnson & Johnson Innovative Medicine; Keiretsu Forum; Linearis Ventures;
Lumira Ventures; Merck; Mitsubishi Canada; Mitsui & Co. Global Investment, Inc.;
NELSA Investments (VCC) Inc; Nimbus Synergies; Novartis; Novo Nordisk;
One Six 8 Ventures; Ontario Brain Institute; Pender Ventures; Pfizer;
Providence Health Care Ventures; Quark Venture; Relentless Venture Fund;
Sixty Degree Capital; Solve FSHD; Spring Impact Capital; SWAN Venture Fund;
Synth-Med Biotechnology; Taiho Ventures, LLC.; UBC Venture Funds; Ventum Financial Corporation.
Event Details:
Dates: Tuesday, November 3, 2026 & Wednesday, November 4, 2026
Location: Vancouver Convention Centre West
Ticket Pricing:
Early Bird Conference and Partnering Pass (until Friday, October 2)
LSBC Members: $449
Non-Members: $549
Regular Conference and Partnering Pass (starting October 3)
LSBC Members: $549
Non-Members: $649
Included in Conference and Partnering Tickets: Access to both d